Glucuronidation of etoposide in human liver microsomes is specifically catalyzed by UDP-glucuronosyltransferase 1A1

Drug Metabolism and Disposition

Volumn 31, Issue 5, 2003, Pages 589-595

  Watanabe, Yuichiro ^a   Nakajima, Miki ^a   Ohashi, Noriko ^b   Kume, Toshiyuki ^b   Yokoi, Tsuyoshi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 NITROPHENOL; BILIRUBIN; ESTRADIOL; ETOPOSIDE; ETOPOSIDE DERIVATIVE; GLUCURONIC ACID; GLUCURONOSYLTRANSFERASE; IMIPRAMINE; ISOENZYME; MORPHINE; TRIMETHYLSILYL DERIVATIVE;

CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG GLUCURONIDATION; ENZYME ACTIVITY; ENZYME KINETICS; ENZYME MECHANISM; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; LIVER MICROSOME; MICHAELIS MENTEN KINETICS; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY;

EID: 0037404036     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: 10.1124/dmd.31.5.589     Document Type: Conference Paper

References (37)

1. Bosma PJ, Chowdhury JR, Bakker C, Gantla S, de Boer A, Oostra BA, Lindhout D, Tytgat GN, Jansen PL, Oude Elferink RP, et al. (1995) The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med 333:1171-1175.
2. Bosma PJ, Seppen J, Goldhoom B, Bakker C, Oude Elferink RP. Chowdhury JR, Chowdhury NR, and Jansen PL (1994) Bilirubin UDP-glucuronosyltransferase I is the only relevant bilirubin glucuronidating isoform in man. J Biol Chem 269:17960-17964.
3. Clark PI and Slevin ML (1987) The clinical pharmacology of etoposide and teniposide. Clin Pharmacokinet 12:223-252.
4. Coffman BL, Rios GR, King CD, and Telphly TR (1997) Human UGT2B7 catalyzes morphine glucuronidation. Drug Metab Dispos 25:1-4.
5. Colombo T, D'Incalci M, Donelli MG, Bartosek I, Benfenati E, Farina P, and Guaitani A (1985) Metabolic studies of a podophyllotoxin derivative (VP16) in the isolated perfused liver. Xenobiotica 15:343-350.
6. D'Incalci M, Rossi C, Zucchetti M, Urso R, Cavalli F, Mangioni C, Willems Y, and Sessa C (1986) Pharmacokinetics of etoposide in patients with abnomial renal and hepatic function. Cancer Res 46:2566-2571.
7. Fisher MB, Paine MF, Strelevitz TJ, and Wrighton SA (2001) The role of hepatic and extrahepatic UDP-glucuronosyltransferases in human drug metabolism. Drug Metab Rev 33:273-297.
8. Gong Q-H, Cho JW, Huang T, Potter C, Gholami N, Basu NK, Kubota S, Carvalho S, Pennington MW, Owens IS, et al. (2001) Thirteen UDP-glucuronosyltransferase gene are encoded at the human UGT1 gene complex locus. Pharmacogenetics 11:357-368.
9. Green MD, Bishop WP, and Tephly TR (1995) Expressed human UGT1.4 protein catalyzed the formation of quaternary ammonium-linked glucuronides. Drug Metab Dispos 23:299-302.
10. Guengerich FP (1994) Analysis and characterization of enzyme, in Principles and Methods of Toxicology (Hayes AW ed) pp 1259-1313, Raven Press, New York.
11. Gunn CH (1938) Hereditary acholuric jaundice in a new mutant strain of rats. J Hered 29:137-139.
12. Hande K, Anthony L, Hamilton R, Bennett R, Sweetman B, and Branch R (1988) Identification of etoposide glucuronide as a major metabolite of etoposide in the rat and rabbit. Cancer Res 48:1829-1834.
13. Hande KR, Wedlund PJ, Noone RM, Wilkinson GR, Greco FA, and Wolff SN (1984) Pharmacokinetics of high-dose etoposide (VP-16-213) administered to cancer patients. Cancer Res 44:379-382.
14. Hanioka N, Junno H, Tanaka-Kagawa T, Nishimura T, and Ando M (2001a) Determination of UDP-glucuronosyltransferase UGT1A6 activity in human and rat liver microsomes by HPLC with UV detection. J Pharm Biomed Anal 25:65-75.
15. Hanioka N, Ozawa S, Junno H, Ando M, Saito Y, and Sawada J (2001b) Human liver UDP-glucuronasyltransferase isoforms involved in the glucuronidation of 7-ethyl-10-hydroxycamptothencin. Xenobiotica 31:687-699.
16. Holthuis JJ, Postmus PE, Van Oort WJ, Hulshoff B, Verleun H, Sleijfer DT, and Mulder NH (1986) Pharmacokinetics of high dose etoposide (VP 16-213). Eur J Cancer Clin Oncol 22:1149-1155.
17. Iyanagi T (1991) Molecular basis of multiple UDP-glucuronosyltransferase isoenzyme deficiencies in the hyperbilirubinemic rat (Gunn rat). J Biol Chem 266:24048-24052.
18. Joel SP, Shah R, Clark PI, and Slevin ML (1996) Predicting etoposide toxicity: relationship to organ function and protein binding. J Clin Oncol 14:257-267.
19. King CD, Green MD, Rios SR, Coffman BL, Owens IS, Bishop WP, and Tephly TR (1996) The glucuronidation of exogenous and endogenous compounds by stably expressed rat and human UDP-glucuronosyltransferase 1.1. Arch Biochem Biophys 332:92-100.
20. Lowry OH, Rosebrough NJ, Farr AL, and Randall RJ (1951) Protein measurement with Folin phenol reagent. J Biol Chem 193:265-275.
21. Mackenzie PI, Owens IS, Burchell B, Bock KW, Bairoch A, Belanger A, Fournel-Gigleux S, Green M, Hum DW, Iyanagi T, et al. (1997) The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics 7:255-269.
22. Miners JO and Mackenzie PI (1991) Drug glucuronidation in humans. Pharmacol Ther 51:347-369.
23. Monaghan G, Ryan M, Seddon R, Hume R, and Burchell B (1996) Genetic variation in bilirubin UDP-glucuronosyltransferase gene promoter and Gilbert's syndrome. Lancet 347:578-581.
24. Nakai Y, Natsume N, Irie T, Suwa M, Kametani S, Nakamaki Y, Hashimoto Y, and Ishibashi M (1986) Tissue and organ distribution of etoposide in rat. Drug Metab Pharmacokinet 1:103-122.
25. Nakajima M, Sakata N, Ohashi N, Kume T, and Yokoi T (2002) Involvement of multiple UDP-glucuronosytransferase 1A isoforms in glucuronidation of 5-(4′-hydroxyphenyl)-5-phenylhydantoin in human liver microsomes. Drug Metab Dispos 30:1250-1256.
26. O'Dwyer PJ, Leyland-Jones B, Alonso MT, Marsoni S, and Wittes RE (1985) Etoposide (VP-16-213): current status of an active anticancer drug. N Engl J Med 312:692-700.
27. Physicians' Desk Reference [PDR] (2000) Etoposide. in Physicians' Desk Reference, 53rd ed., pp 888-889, Medical Economic Company, Inc., Montvale. NJ.
28. Relling MV, Nemec J, Schuetz EG, Schuetz JD, Gonzalez FJ, and Korzekwa KR (1994) O-Demethylation of epipodophyllotoxins is catalyzed by human cytochrome P450 3A4. Mol Pharmacol 45:352-358.
29. Ritter JK (2000) Roles of glucuronidation and UDP-glucuronosyltransferases in xenobiotic bioactivation reactions. Chem Biol Interact 129:171-193.
30. Ross W, Rowe T, Glisson B, Yalowich J, and Liu L (1984) Role of topoisomerase II in mediating epipodophyllotoxin-induced DNA cleavage. Cancer Res 44:5857-5860.
31. Sato H, Aono S, Kashiwamata S, and Koiwai O (1991) Genetic defect of bilirubin UDP-glucuronosyltransferase in the hyperbilirubinemic Gunn rat. Biochem Biophys Res Commun 177:1161-1164.
32. Sinkule JA, Hutson P, Hayes FA, Etcubanas E, and Evans W (1984) Pharmacokinetics of etoposide (VP16) in children and adolescents with refractory solid tumors. Cancer Res 44:3109-3113.
33. Stähelin HF and von Wartburg A (1991) The chemical and biological route from podophyllotoxin glucoside to etoposide: ninth Cain memorial award lecture. Cancer Res 51:5-15.
34. Stewart CF (1994) Use of etoposide in patients with organ dysfunction: pharmacokinetic and pharmacodynamic considerations. Cancer Chemother Pharmacol 34 (Suppl):S76-S83.
35. Tukey RH and Strassburg CP (2000) Human UDP-glucuronosyltransferase: metabolism, expression and disease. Annu Rev Pharmacol Toxicol 40:581-616.
36. Watanabe Y. Nakajima M. and Yokoi T (2002) Troglitazone glucuranidation in human liver and intestine microsomes: high catalytic activity of UGT1A8 and UGTIA10. Drug Metab Dispos 30:1462-1469.
37. Yamamoto K, Sato H, Fujiyama Y, Doida Y, and Bamba T (1998) Contribution of two missense mutations (G71R and Y486D) of the bilirubin UDP glycosyltransferase (UGT1A1) gene to phenotypes of Gilbert's syndrome and Crigler-Najjar syndrome type II. Biochim Biophys Acta 1406:267-273.